Media coverage
1
Media coverage
Title Phase 1b/2, Open Label, Repeat Dose, Dose Escalation Study of ND-L02-s0201 Injection in Subjects With Moderate to Extensive Fibrosis (METAVIR F3-4) Media name/outlet Clinical Trials.gov Country United States Date 10/2/18 Persons Eric J Lawitz